This document provides an overview of Ebola Virus Disease (EVD) including the current outbreak in Uganda, clinical diagnosis and management, contact tracing, and UN resources. It discusses that EVD is caused by several species of Ebolavirus including Zaire and Sudan strains. The current outbreak in Uganda is caused by the Sudan strain for which there is no approved vaccine. Clinical signs include fever, fatigue and bleeding. Diagnosis involves assessing exposure risk factors and testing blood via PCR. Management focuses on supportive care like fluid resuscitation, electrolyte replacement, and treating symptoms and potential bacterial infections. Contact tracing and monitoring is also important to control outbreaks.
Ebola virus disease is a severe, often fatal illness caused by the Ebola virus. The virus was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. The 2014 outbreak in West Africa was the largest in history, infecting thousands and killing over 11,000. The virus is transmitted through direct contact with body fluids of infected humans or animals. Common symptoms include fever, headache, muscle pain and weakness. While there is no approved vaccine, treatment involves supportive care to improve symptoms.
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...Arthur Dessi Roman
Interim Guidelines in the Management and Prevention of Ebola Virus Disease presented by Dr. Arthur Dessi Roman on November 28, 2014 at the PSMID 36th Annual Convention
The document provides an overview of HIV/AIDS including:
1. The history and epidemiology of HIV/AIDS globally and in Egypt. HIV was first identified in 1981 and transmission occurs through unprotected sex, blood transfusions, and mother-to-child. Rates in Egypt have increased in recent years.
2. The life cycle and stages of HIV infection from initial binding to T-cells through replication and progression to AIDS if untreated.
3. Effective prevention methods including antiretroviral treatment for pregnant women, voluntary medical male circumcision, pre-exposure prophylaxis, and consistent condom use which can reduce risk of transmission by over 90%.
In light of the rise in MERS CoV cases in the Middle East the Yale-Tulane ESF-8 Planning and Response Program has produced this special report. It was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested.
Prevention and Control of AIDS for World AIDS dayMostafa Mahmoud
The document discusses prevention and control of AIDS, including:
1. HIV can be transmitted through certain body fluids like blood, semen, vaginal secretions, and breast milk. The most common modes of transmission are unprotected sex and sharing needles.
2. Prevention methods include condom use, pre-exposure prophylaxis, treatment of infected mothers, sterile needle programs, and post-exposure prophylaxis for healthcare workers with needlestick injuries.
3. Healthcare workers should follow standard precautions like hand hygiene, personal protective equipment, and safe disposal of needles to prevent transmission between patients and staff. Proper sterilization and cleaning of medical equipment is also important.
The document summarizes information about Ebola virus and the use of blood transfusion as a potential treatment. It discusses:
1) Ebola virus was first identified in 1976 and causes viral hemorrhagic fever. The 2013-2014 outbreak in West Africa was the largest in history.
2) With no vaccine or reliable drug treatment, symptomatic care including blood transfusion from recovered patients has been used.
3) For blood transfusion to be effective and safe as a treatment, donors must be properly screened and blood must be type-matched to the recipient to avoid complications.
The document discusses three diseases: cholera, SARS, and Ebola. It provides details on the causative agents, symptoms, transmission, treatment and prevention of each disease. Cholera is caused by Vibrio cholerae bacteria and causes watery diarrhea. SARS is caused by a coronavirus and symptoms include fever and breathing difficulties. Ebola virus disease is severe and often fatal, caused by one of five Ebola virus strains, and spreads through contact with infected body fluids.
Ebola virus disease is a severe, often fatal illness caused by the Ebola virus. The virus was first discovered in 1976 near the Ebola River in the Democratic Republic of Congo. The 2014 outbreak in West Africa was the largest in history, infecting thousands and killing over 11,000. The virus is transmitted through direct contact with body fluids of infected humans or animals. Common symptoms include fever, headache, muscle pain and weakness. While there is no approved vaccine, treatment involves supportive care to improve symptoms.
Interim Guidelines in the Management and Prevention of Ebola Virus Disease as...Arthur Dessi Roman
Interim Guidelines in the Management and Prevention of Ebola Virus Disease presented by Dr. Arthur Dessi Roman on November 28, 2014 at the PSMID 36th Annual Convention
The document provides an overview of HIV/AIDS including:
1. The history and epidemiology of HIV/AIDS globally and in Egypt. HIV was first identified in 1981 and transmission occurs through unprotected sex, blood transfusions, and mother-to-child. Rates in Egypt have increased in recent years.
2. The life cycle and stages of HIV infection from initial binding to T-cells through replication and progression to AIDS if untreated.
3. Effective prevention methods including antiretroviral treatment for pregnant women, voluntary medical male circumcision, pre-exposure prophylaxis, and consistent condom use which can reduce risk of transmission by over 90%.
In light of the rise in MERS CoV cases in the Middle East the Yale-Tulane ESF-8 Planning and Response Program has produced this special report. It was compiled entirely from open source materials. Please feel free to forward the report to anyone who might be interested.
Prevention and Control of AIDS for World AIDS dayMostafa Mahmoud
The document discusses prevention and control of AIDS, including:
1. HIV can be transmitted through certain body fluids like blood, semen, vaginal secretions, and breast milk. The most common modes of transmission are unprotected sex and sharing needles.
2. Prevention methods include condom use, pre-exposure prophylaxis, treatment of infected mothers, sterile needle programs, and post-exposure prophylaxis for healthcare workers with needlestick injuries.
3. Healthcare workers should follow standard precautions like hand hygiene, personal protective equipment, and safe disposal of needles to prevent transmission between patients and staff. Proper sterilization and cleaning of medical equipment is also important.
The document summarizes information about Ebola virus and the use of blood transfusion as a potential treatment. It discusses:
1) Ebola virus was first identified in 1976 and causes viral hemorrhagic fever. The 2013-2014 outbreak in West Africa was the largest in history.
2) With no vaccine or reliable drug treatment, symptomatic care including blood transfusion from recovered patients has been used.
3) For blood transfusion to be effective and safe as a treatment, donors must be properly screened and blood must be type-matched to the recipient to avoid complications.
The document discusses three diseases: cholera, SARS, and Ebola. It provides details on the causative agents, symptoms, transmission, treatment and prevention of each disease. Cholera is caused by Vibrio cholerae bacteria and causes watery diarrhea. SARS is caused by a coronavirus and symptoms include fever and breathing difficulties. Ebola virus disease is severe and often fatal, caused by one of five Ebola virus strains, and spreads through contact with infected body fluids.
This document provides information from a training bulletin about Ebola virus disease (EVD) for EMS providers, including that EVD can only be transmitted through direct contact with bodily fluids from a symptomatic, infected person. It outlines signs and symptoms of EVD, precautions EMS providers should take when evaluating patients, and disinfection procedures after transporting a patient. It notes collaboration between EMS agencies and health organizations to provide timely information during the Ebola outbreak.
This document provides information about HIV and AIDS. It discusses that HIV is a retrovirus that infects and destroys T-cells of the immune system. Over time, this infection can develop into AIDS. The two main types of HIV that cause AIDS are HIV-1, which is most common worldwide, and HIV-2, which is mainly found in West Africa. HIV can be transmitted through unprotected sex, blood transmission, mother-to-child transmission, and sharing needles. While treatment with antiretroviral drugs can suppress the virus and prevent transmission, there is currently no cure for HIV/AIDS.
2014 2015-update-on-ebola-virus-dr-bryna-warshawsky (1)Elyas Mohammed
This document provides an overview and summary of three topics: Ebola virus disease, Enterovirus D68, and influenza. For Ebola, it discusses the origins and progression of the current outbreak in West Africa, symptoms and transmission of the disease, treatment and prevention strategies. For Enterovirus D68, it summarizes the current outbreak in the US and Canada and associated acute flaccid paralysis cases. For influenza, it reviews past seasonal patterns in Ontario and the vaccine strains for the current year.
The document discusses Ebola virus disease (EVD), including that it is a deadly virus transmitted through contact with infected body fluids that causes hemorrhagic fever. It outlines the virus's history, symptoms, transmission, treatments being tested including vaccines, and current outbreak statistics showing exponential growth in West Africa.
The document discusses World AIDS Day which is held annually on December 1st to raise awareness about HIV/AIDS and show support for those living with the disease. It provides information about the themes, transmission, stages of HIV infection, testing, and treatment. The document also outlines the goals of increasing HIV testing and treatment to work towards eliminating HIV/AIDS by 2030.
HIV originated from chimpanzees in West Africa and was transmitted to humans. The earliest known case of HIV in a human was detected in 1959 in the Democratic Republic of Congo. Antiretroviral therapy uses HIV medicines to treat infection and suppress viral load, preventing transmission. Factors like viral load, condom use, and adherence to medication determine likelihood of HIV transmission. Common signs of HIV infection include fever, fatigue, swollen lymph nodes, and skin rashes.
CDC Presentation, Los Angeles, CA - 11/7/14drenfeld
The document discusses healthcare personnel preparedness for Ebola in the United States. It provides an overview of the current Ebola outbreak in West Africa, transmission of Ebola in the US, Ebola basics including symptoms and diagnosis, and how Ebola spreads. It emphasizes the importance of early identification, isolation, and informing health departments of possible Ebola cases. Recommendations are provided for infection control in ambulatory settings, emergency medical services, and emergency departments. Key aspects of safe Ebola patient care like personal protective equipment, designated patient areas, and limiting caregivers are also summarized.
HIV in Pregnancy
Dr. ARCHANA VERMA
1) HIV is a retrovirus that can be transmitted from mother to child during pregnancy, childbirth, or breastfeeding. Left untreated, the risk of mother-to-child transmission is 15-45%.
2) Treatment involves antiretroviral therapy for the mother during pregnancy and delivery, and for the newborn for 4-6 weeks to prevent transmission. Mode of delivery and avoiding breastfeeding can also reduce risk.
3) With treatment, the risk of mother-to-child HIV transmission can be reduced to less than 2%. Proper antenatal care, delivery management, and postpartum care and testing of
HIV DURING PREGNANCY, this is very common and very dangerous disease during pregnancy. this is for medical and nursing student. i tried to make understand of students.
HIV in Pregnancy
The document discusses HIV in pregnancy, including its characteristics, epidemiology, pathogenesis, diagnosis, treatment, and prevention of mother-to-child transmission. It notes that antiretroviral therapy administered to the mother during pregnancy and delivery, as well as to the newborn, can reduce transmission rates to less than 2%. Treatment options aim to prevent mother-to-child transmission through antiviral regimens and by avoiding breastfeeding. Screening and treatment of any genital infections in the mother are also important to prevent transmission of HIV from mother to child.
This document provides information about HIV testing and the implications of test results. It discusses the various types of HIV tests including rapid tests, ELISA, and Western blot. A positive test result means antibodies to HIV have been detected, while a negative result means antibodies were not detected, though the person could still be in the window period. Interpretation of results and the need for counseling before and after testing is emphasized. Symptoms of infection and potential complications are outlined. Treatment involves antiretroviral drugs to suppress the virus and medications to prevent opportunistic infections.
An introduction to the 2014 West Africa Ebola outbreak for educational use, with additional sources for health professionals in need of up-to-date information.
Updated on 7th December, 2014, with additional infographics and WHO data.
Infographics may be requested for professional use on a creative commons/source attribution basis (micrognome.priobe.net). An interactive version will be available for educational use via the Nearpod share site.
This document summarizes a seminar presentation on Ebola virus disease (EVD). It provides an overview of EVD outbreaks, case definitions, epidemiology, clinical presentation, diagnosis, treatment, and control/prevention. Key points include: EVD is caused by infection with Ebola virus and transmitted through contact with infected body fluids; symptoms range from fever and fatigue to vomiting and hemorrhaging; diagnosis involves virus detection through antigen/antibody tests or PCR; treatment is supportive care as no vaccine currently exists; control relies on isolation, contact tracing, and barrier precautions.
HIV/AIDS is caused by the HIV virus which weakens the immune system. It is transmitted through unprotected sex, contaminated blood, sharing needles, and from mother to child during pregnancy, delivery, or breastfeeding. As the virus progresses it can cause opportunistic infections and cancers. India has a large population affected due to transmission among high risk groups like sex workers, clients, and drug users. Prevention methods aim to reduce transmission through awareness, testing, treatment, and vaccination programs.
This document provides information about Ebola virus disease. It discusses that Ebola is a severe and often fatal illness caused by the Ebola virus. The virus is transmitted through contact with bodily fluids of infected humans or animals. Symptoms include fever, fatigue, vomiting and diarrhea. Diagnosis involves virus detection through blood tests and PCR. Treatment focuses on supportive care, though vaccines and treatments are being developed. Prevention relies on avoiding contact with infected individuals and controlling infections in healthcare settings.
The document provides information about Ebola virus disease (EVD) including how it spreads, symptoms, treatment, and prevention. It notes that EVD is currently affecting parts of the Democratic Republic of Congo (DRC) and surrounding countries. Key points include: EVD spreads through contact with bodily fluids and can survive on surfaces; symptoms include fever, vomiting and diarrhea; treatment focuses on rehydration and symptom management; prevention emphasizes handwashing, avoiding contact with infected individuals and animals, and promptly reporting potential exposures. The document outlines Burundi's preparedness efforts to detect and isolate potential cases through screening, training, and raising awareness.
This document provides an overview of Ebola Virus Disease (EVD) for the purposes of training healthcare workers in Kenya. It begins with objectives to update participants on the ongoing EVD outbreak in Uganda and orient them to prevention and control strategies. It then covers the etiology of EVD, modes of transmission, clinical presentation and diagnosis. Treatment involves supportive care as there is no cure. Prevention strategies focus on avoiding contact with body fluids, safe burials, and increasing awareness. The training aims to build capacity to detect and respond to potential EVD cases spreading from Uganda into Kenya.
This document provides guidelines on when to start antiretroviral therapy (ART) in adults and adolescents living with HIV. It recommends that all HIV-infected individuals start ART as soon as possible for their health and to prevent transmission. A clinical assessment should be performed to determine conditions that will help select an appropriate ART regimen. ART eligibility is based on WHO clinical staging, CD4 count, viral load, and public health considerations. First-line regimens generally consist of two nucleoside reverse transcriptase inhibitors plus a non-nucleoside reverse transcriptase inhibitor or integrase strand transfer inhibitor. Important factors for countries adapting WHO guidelines include accessibility, quality of care, equity, efficiency and sustainability. Immune reconstitution
Decormart Studio is widely recognized as one of the best interior designers in Bangalore, known for their exceptional design expertise and ability to create stunning, functional spaces. With a strong focus on client preferences and timely project delivery, Decormart Studio has built a solid reputation for their innovative and personalized approach to interior design.
EASY TUTORIAL OF HOW TO USE CAPCUT BY: FEBLESS HERNANEFebless Hernane
CapCut is an easy-to-use video editing app perfect for beginners. To start, download and open CapCut on your phone. Tap "New Project" and select the videos or photos you want to edit. You can trim clips by dragging the edges, add text by tapping "Text," and include music by selecting "Audio." Enhance your video with filters and effects from the "Effects" menu. When you're happy with your video, tap the export button to save and share it. CapCut makes video editing simple and fun for everyone!
More Related Content
Similar to ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf
This document provides information from a training bulletin about Ebola virus disease (EVD) for EMS providers, including that EVD can only be transmitted through direct contact with bodily fluids from a symptomatic, infected person. It outlines signs and symptoms of EVD, precautions EMS providers should take when evaluating patients, and disinfection procedures after transporting a patient. It notes collaboration between EMS agencies and health organizations to provide timely information during the Ebola outbreak.
This document provides information about HIV and AIDS. It discusses that HIV is a retrovirus that infects and destroys T-cells of the immune system. Over time, this infection can develop into AIDS. The two main types of HIV that cause AIDS are HIV-1, which is most common worldwide, and HIV-2, which is mainly found in West Africa. HIV can be transmitted through unprotected sex, blood transmission, mother-to-child transmission, and sharing needles. While treatment with antiretroviral drugs can suppress the virus and prevent transmission, there is currently no cure for HIV/AIDS.
2014 2015-update-on-ebola-virus-dr-bryna-warshawsky (1)Elyas Mohammed
This document provides an overview and summary of three topics: Ebola virus disease, Enterovirus D68, and influenza. For Ebola, it discusses the origins and progression of the current outbreak in West Africa, symptoms and transmission of the disease, treatment and prevention strategies. For Enterovirus D68, it summarizes the current outbreak in the US and Canada and associated acute flaccid paralysis cases. For influenza, it reviews past seasonal patterns in Ontario and the vaccine strains for the current year.
The document discusses Ebola virus disease (EVD), including that it is a deadly virus transmitted through contact with infected body fluids that causes hemorrhagic fever. It outlines the virus's history, symptoms, transmission, treatments being tested including vaccines, and current outbreak statistics showing exponential growth in West Africa.
The document discusses World AIDS Day which is held annually on December 1st to raise awareness about HIV/AIDS and show support for those living with the disease. It provides information about the themes, transmission, stages of HIV infection, testing, and treatment. The document also outlines the goals of increasing HIV testing and treatment to work towards eliminating HIV/AIDS by 2030.
HIV originated from chimpanzees in West Africa and was transmitted to humans. The earliest known case of HIV in a human was detected in 1959 in the Democratic Republic of Congo. Antiretroviral therapy uses HIV medicines to treat infection and suppress viral load, preventing transmission. Factors like viral load, condom use, and adherence to medication determine likelihood of HIV transmission. Common signs of HIV infection include fever, fatigue, swollen lymph nodes, and skin rashes.
CDC Presentation, Los Angeles, CA - 11/7/14drenfeld
The document discusses healthcare personnel preparedness for Ebola in the United States. It provides an overview of the current Ebola outbreak in West Africa, transmission of Ebola in the US, Ebola basics including symptoms and diagnosis, and how Ebola spreads. It emphasizes the importance of early identification, isolation, and informing health departments of possible Ebola cases. Recommendations are provided for infection control in ambulatory settings, emergency medical services, and emergency departments. Key aspects of safe Ebola patient care like personal protective equipment, designated patient areas, and limiting caregivers are also summarized.
HIV in Pregnancy
Dr. ARCHANA VERMA
1) HIV is a retrovirus that can be transmitted from mother to child during pregnancy, childbirth, or breastfeeding. Left untreated, the risk of mother-to-child transmission is 15-45%.
2) Treatment involves antiretroviral therapy for the mother during pregnancy and delivery, and for the newborn for 4-6 weeks to prevent transmission. Mode of delivery and avoiding breastfeeding can also reduce risk.
3) With treatment, the risk of mother-to-child HIV transmission can be reduced to less than 2%. Proper antenatal care, delivery management, and postpartum care and testing of
HIV DURING PREGNANCY, this is very common and very dangerous disease during pregnancy. this is for medical and nursing student. i tried to make understand of students.
HIV in Pregnancy
The document discusses HIV in pregnancy, including its characteristics, epidemiology, pathogenesis, diagnosis, treatment, and prevention of mother-to-child transmission. It notes that antiretroviral therapy administered to the mother during pregnancy and delivery, as well as to the newborn, can reduce transmission rates to less than 2%. Treatment options aim to prevent mother-to-child transmission through antiviral regimens and by avoiding breastfeeding. Screening and treatment of any genital infections in the mother are also important to prevent transmission of HIV from mother to child.
This document provides information about HIV testing and the implications of test results. It discusses the various types of HIV tests including rapid tests, ELISA, and Western blot. A positive test result means antibodies to HIV have been detected, while a negative result means antibodies were not detected, though the person could still be in the window period. Interpretation of results and the need for counseling before and after testing is emphasized. Symptoms of infection and potential complications are outlined. Treatment involves antiretroviral drugs to suppress the virus and medications to prevent opportunistic infections.
An introduction to the 2014 West Africa Ebola outbreak for educational use, with additional sources for health professionals in need of up-to-date information.
Updated on 7th December, 2014, with additional infographics and WHO data.
Infographics may be requested for professional use on a creative commons/source attribution basis (micrognome.priobe.net). An interactive version will be available for educational use via the Nearpod share site.
This document summarizes a seminar presentation on Ebola virus disease (EVD). It provides an overview of EVD outbreaks, case definitions, epidemiology, clinical presentation, diagnosis, treatment, and control/prevention. Key points include: EVD is caused by infection with Ebola virus and transmitted through contact with infected body fluids; symptoms range from fever and fatigue to vomiting and hemorrhaging; diagnosis involves virus detection through antigen/antibody tests or PCR; treatment is supportive care as no vaccine currently exists; control relies on isolation, contact tracing, and barrier precautions.
HIV/AIDS is caused by the HIV virus which weakens the immune system. It is transmitted through unprotected sex, contaminated blood, sharing needles, and from mother to child during pregnancy, delivery, or breastfeeding. As the virus progresses it can cause opportunistic infections and cancers. India has a large population affected due to transmission among high risk groups like sex workers, clients, and drug users. Prevention methods aim to reduce transmission through awareness, testing, treatment, and vaccination programs.
This document provides information about Ebola virus disease. It discusses that Ebola is a severe and often fatal illness caused by the Ebola virus. The virus is transmitted through contact with bodily fluids of infected humans or animals. Symptoms include fever, fatigue, vomiting and diarrhea. Diagnosis involves virus detection through blood tests and PCR. Treatment focuses on supportive care, though vaccines and treatments are being developed. Prevention relies on avoiding contact with infected individuals and controlling infections in healthcare settings.
The document provides information about Ebola virus disease (EVD) including how it spreads, symptoms, treatment, and prevention. It notes that EVD is currently affecting parts of the Democratic Republic of Congo (DRC) and surrounding countries. Key points include: EVD spreads through contact with bodily fluids and can survive on surfaces; symptoms include fever, vomiting and diarrhea; treatment focuses on rehydration and symptom management; prevention emphasizes handwashing, avoiding contact with infected individuals and animals, and promptly reporting potential exposures. The document outlines Burundi's preparedness efforts to detect and isolate potential cases through screening, training, and raising awareness.
This document provides an overview of Ebola Virus Disease (EVD) for the purposes of training healthcare workers in Kenya. It begins with objectives to update participants on the ongoing EVD outbreak in Uganda and orient them to prevention and control strategies. It then covers the etiology of EVD, modes of transmission, clinical presentation and diagnosis. Treatment involves supportive care as there is no cure. Prevention strategies focus on avoiding contact with body fluids, safe burials, and increasing awareness. The training aims to build capacity to detect and respond to potential EVD cases spreading from Uganda into Kenya.
This document provides guidelines on when to start antiretroviral therapy (ART) in adults and adolescents living with HIV. It recommends that all HIV-infected individuals start ART as soon as possible for their health and to prevent transmission. A clinical assessment should be performed to determine conditions that will help select an appropriate ART regimen. ART eligibility is based on WHO clinical staging, CD4 count, viral load, and public health considerations. First-line regimens generally consist of two nucleoside reverse transcriptase inhibitors plus a non-nucleoside reverse transcriptase inhibitor or integrase strand transfer inhibitor. Important factors for countries adapting WHO guidelines include accessibility, quality of care, equity, efficiency and sustainability. Immune reconstitution
Similar to ID_EVD_SudanVirusUganda_EVDOverview_2022-11-02 (1).pdf (20)
Decormart Studio is widely recognized as one of the best interior designers in Bangalore, known for their exceptional design expertise and ability to create stunning, functional spaces. With a strong focus on client preferences and timely project delivery, Decormart Studio has built a solid reputation for their innovative and personalized approach to interior design.
EASY TUTORIAL OF HOW TO USE CAPCUT BY: FEBLESS HERNANEFebless Hernane
CapCut is an easy-to-use video editing app perfect for beginners. To start, download and open CapCut on your phone. Tap "New Project" and select the videos or photos you want to edit. You can trim clips by dragging the edges, add text by tapping "Text," and include music by selecting "Audio." Enhance your video with filters and effects from the "Effects" menu. When you're happy with your video, tap the export button to save and share it. CapCut makes video editing simple and fun for everyone!
Storytelling For The Web: Integrate Storytelling in your Design ProcessChiara Aliotta
In this slides I explain how I have used storytelling techniques to elevate websites and brands and create memorable user experiences. You can discover practical tips as I showcase the elements of good storytelling and its applied to some examples of diverse brands/projects..
Architectural and constructions management experience since 2003 including 18 years located in UAE.
Coordinate and oversee all technical activities relating to architectural and construction projects,
including directing the design team, reviewing drafts and computer models, and approving design
changes.
Organize and typically develop, and review building plans, ensuring that a project meets all safety and
environmental standards.
Prepare feasibility studies, construction contracts, and tender documents with specifications and
tender analyses.
Consulting with clients, work on formulating equipment and labor cost estimates, ensuring a project
meets environmental, safety, structural, zoning, and aesthetic standards.
Monitoring the progress of a project to assess whether or not it is in compliance with building plans
and project deadlines.
Attention to detail, exceptional time management, and strong problem-solving and communication
skills are required for this role.
Maximize Your Content with Beautiful Assets : Content & Asset for Landing Page pmgdscunsri
Figma is a cloud-based design tool widely used by designers for prototyping, UI/UX design, and real-time collaboration. With features such as precision pen tools, grid system, and reusable components, Figma makes it easy for teams to work together on design projects. Its flexibility and accessibility make Figma a top choice in the digital age.
Visual Style and Aesthetics: Basics of Visual Design
Visual Design for Enterprise Applications
Range of Visual Styles.
Mobile Interfaces:
Challenges and Opportunities of Mobile Design
Approach to Mobile Design
Patterns
Technoblade The Legacy of a Minecraft Legend.Techno Merch
Technoblade, born Alex on June 1, 1999, was a legendary Minecraft YouTuber known for his sharp wit and exceptional PvP skills. Starting his channel in 2013, he gained nearly 11 million subscribers. His private battle with metastatic sarcoma ended in June 2022, but his enduring legacy continues to inspire millions.
Practical eLearning Makeovers for EveryoneBianca Woods
Welcome to Practical eLearning Makeovers for Everyone. In this presentation, we’ll take a look at a bunch of easy-to-use visual design tips and tricks. And we’ll do this by using them to spruce up some eLearning screens that are in dire need of a new look.
Explore the essential graphic design tools and software that can elevate your creative projects. Discover industry favorites and innovative solutions for stunning design results.
ARENA - Young adults in the workplace (Knight Moves).pdfKnight Moves
Presentations of Bavo Raeymaekers (Project lead youth unemployment at the City of Antwerp), Suzan Martens (Service designer at Knight Moves) and Adriaan De Keersmaeker (Community manager at Talk to C)
during the 'Arena • Young adults in the workplace' conference hosted by Knight Moves.
1. 0
Ebola Virus Disease (EVD):
Overview, Diagnosis &
Clinical Management
Dr. Esther Tan, MD MPH
Senior Medical Officer
Head of Public Health Section
Division of Healthcare Management & Occupational Safety and Health (DHMOSH)
United Nations
2. 1
Outline
1. Introduction
2. UN Resources
3. Clinical & Lab Diagnosis
4. Contact Management
5. Clinical Management
Note: Complete WHO guidelines for the management of
EVD patients can be found here:
Optimized Supportive Care for Ebola Virus Disease
https://apps.who.int/iris/handle/10665/325000
Implementation and management of contact tracing for
Ebola virus disease
https://www.who.int/publications/i/item/WHO-EVD-Guidance-
Contact-15.1
4. 3
Introduction
• First appeared in 1976 in 2 simultaneous outbreaks in
South Sudan and DRC
• DRC outbreak occurred in a village near the Ebola River
• Virus family Filoviridae includes three genera: Cuevavirus, Marburgvirus
and Ebolavirus
• Within the genus Ebolavirus, six species identified including Zaire and
Sudan
• 2014-2016 outbreak in West Africa was the largest outbreak since –
starting from Guinea and moving across to Sierra Leone and Liberia
5. 4
Introduction
• Ebola virus disease, formerly known as Ebola haemorrhagic fever
• Fruit bats of Pteropodidae family are natural Ebola virus hosts
• Rare, but severe and often fatal illness in humans
• Transmitted from wild animals, and spread into human population through
human-to-human transmission
• Average CFR is around 50% (range 25-90%)
• Community engagement key to successful control
• Case management, infection prevention and control
practices, surveillance and contact tracing,
good lab service, safe and dignified burials, social
mobilisation
6. 5
Current Outbreak in Uganda
• On 20 September, health authorities in the
Republic of Uganda declared an outbreak of
EVD caused by Sudan ebolavirus (SUDV)
• As of today, 2 November, there were:
– Confirmed cases:129
– Confirmed Deaths: 37
– CFR = 28%
– Recoveries: 43
• This is not the first Ebola outbreak caused by
the Sudan strain. 7 previous outbreaks have
been reported, four of which occurred in
Uganda and three in Sudan
7. 6
Current Sudan Strain Has
No Approved Vaccine
• EVD vaccine has only been approved to
protect against the Zaire strain of Ebola
• Three candidate vaccines may be trialed
but have yet to be specifically tested against
the Sudan strain
9. 8
UN Medical Directors’ EVD Risk Mitigation Plan
(English/French available)
https://hr.un.org/sites/hr.un.org/files/file/refmaterials/ID_Ebola_UNMDRMP_2021-08-%2027.pdf
https://hr.un.org/sites/hr.un.org/files/file/refmaterials/ID_Ebola_UNMDRMP_2021-08-%2027%20FR.pdf
10. 9
UN Ebola Preparedness and Response:
A Checklist for UN Health Facilities
(English & French available)
https://hr.un.org/sites/hr.un.org/files/Ebola%20Checklist_DHMOSHPH_2019-05_FINAL_Eng_2.pdf
https://hr.un.org/sites/hr.un.org/files/Ebola%20Checklist_DHMOSHPH_2019-05_FINAL_Fr_0.pdf
11. 10
UN Guidance: PPE Stocks &
Calculation of Quantities Needed
• Use the following PPE calculator to procure needed
supplies: https://www.cdc.gov/vhf/ebola/healthcare-
us/ppe/calculator.html
• This calculator provides you the necessary number
of individual PPE needed per VHF/EVD patient seen
by your facility
• If you need training on how to use the EVD PPE
Calculator, please watch this training video by
DHMOSH Public Health at
https://www.youtube.com/watch?v=EyJqhhLwgX4
12. 11
EVD Online Courses Conducted by WHO
ePROTECT Ebola (EN) https://openwho.org/courses/e-protect
Ebola: Clinical management of Ebola virus disease https://openwho.org/courses/ebola-clinical-management
Ebola: GO 2.0 https://openwho.org/courses/GO-en
14. 13
Signs & Symptoms of EVD
• Can be sudden and include:
– Fever, fatigue, muscle pain,
– Headache, sore throat
• This is followed by:
– Vomitting, diarrhoea, rash, symptoms of kidney and liver function,
internal and external bleeding (e.g. from gums or blood in stools.
– Lab findings include low white blood cell and platelet counts and
elevated liver enzymes
15. 14
Disease Progression of EVD
• Not contagious until symptoms
develop
• Wet symptoms develop approx.
day 4 of illness
• Patient becomes more and more
contagious as the illness
advances
• Without treatment, death occurs 7-
10 days after illness onset
• Amount of Ebola virus in the body
is highest at the time of death
16. 15
Suspect / Confirmed Case Definition
Suspect Case
– Signs and symptoms consistent with Ebola virus
infection AND
– An epidemiological risk factor (exposure to blood
or body fluids of infected person, objects
contaminated from infected person, infected fruit
bats or non-human primates, semen from a man
recovering from Ebola)
Confirmed Case
– Laboratory-confirmed diagnostic evidence of
Ebola virus infection
18. 17
Considerations for Clinical Diagnosis
• Signs and symptoms of SUDV are similar to other infectious diseases
and conditions such as:
– Malaria
– Typhoid fever
– Meningitis
– Pregnancy
• Use proper precautions when testing due to possibility of co-infection
with the above
• Pregnant women should be tested rapidly if Ebola is suspected
19. 18
Confirmation of Diagnosis by Lab Testing
• Ebola virus is detected in blood only after
onset of symptoms, most notably fever,
• However, it may take up to 3 days after
symptoms begin for the virus to reach
detectable levels
• Polymerase chain reaction (PCR) is one
of the most commonly used diagnostic
methods because of its ability to detect low
levels of Ebola virus.
• WHO recommends PCR tests as gold
standard for Ebola confirmation.
20. 19
What To Do for Test-Negative
Suspect EVD Cases?
• PCR tests are often negative in patients
with symptoms less than 3 days
• Repeat the test at 72 or more hours after
onset of symptoms
• Keep patient in suspect area until a sample
taken 72 hours after symptoms begin is
negative
• Testing negative does not equal to having
immunity
• Repeat diagnostic testing when indicated
21. 20
Confirmation of Diagnosis by Lab Testing
• According to WHO:
– Rapid antigen detection tests can be used
in remote settings where PCR tests are not
readily available
– However, such rapid tests are
recommended only for screening purposes
as part of surveillance activities
– If rapid antigen test is positive, it should
always be confirmed with a PCR test
22. 21
Specimen Collection
• The preferred specimens for diagnosis
include:
– Whole blood collected in
ethylenediaminetetraacetic acid
(EDTA) from live patients exhibiting
symptoms
– Oral fluid specimen stored in
universal transport medium collected
from deceased patients or when
blood collection is not possible
23. 22
Specimen Collection & Transport
• Blood and other samples from
symptomatic EVD patients are
highly infectious
• All biological specimens should be
packaged using the triple packaging
system when transported nationally
and internationally
• Laboratory testing on non-inactivated
samples should be conducted under
maximum biological containment
conditions
25. 24
What To Do if Someone Has Been Exposed?
• If you’re exposed, immediately clean the area
with soap and water or in the case of mucous
membrane exposure, clean with water
• Immediately call your medical practitioner,
UN physician or your organisation’s medical
services for guidance
• At this time, there is no vaccine available for
the Sudan ebolavirus (SUDV)
– However, vaccines may be trialed for SUDV
in the near future
26. 25
What To Do if Someone Has Been Exposed?
• Assess for any other blood borne virus (BBV)
exposure (HIV, Hep B, Hep C) and receive
prophylaxis and counseling as appropriate.
• Monitor contacts daily for Ebola symptoms for 21
days counting from the last day of exposure
• Educate contacts on signs and symptoms of Ebola,
next steps if s/s present, and preventing
transmission to family members
• Contacts should not travel until cleared by health
officials
• Local guidelines should be followed
28. 27
Clinical Management
• Predominantly supportive care
• Aggressively replace volume loss from
diarrhea, vomiting .etc
• Oral hydration with ORS (even if patient
does not have diarrhea or vomiting)
• IV resuscitation with Ringer’s lactate (contains
some potassium)
• Replace potassium and magnesium loss, likely
significant for patients with diarrhea
• There are no approved therapies specific for EVD
Sudan virus
29. 28
This presentation contains materials from CDC, MSF, and WHO 28
Managing the Treatable Manifestations &
Complications of EVD
q Fever and pain
§ Paracetamol (acetaminophen)
§ Do NOT use NSAIDs (concern for
thrombocytopenia, bleeding)
§ Opioids (caution in hypotensive patients; may
reduce gut transit in diarrhea)
q Nausea and vomiting
§ Promethazine, metoclopramide, ondansetron
q Diarrhea
§ Aggressive oral rehydration
§ IV hydration when possible for those unable to
take orally
§ Role of anti-motility agents uncertain
q Dyspepsia
§ Cimetidine or omeprazole
q Agitation
§ Diazepam or haloperidol
q Malaria (empiric therapy for
all, or treat rapid diagnostic
test positives)
q Bacterial co-infections or gut
translocation
§ Empiric antibiotic therapy aimed at gut
pathogens (e.g., cefepime)
30. 29
WHO’s Guidelines on
EVD Clinical Management
1. Systematic assessment and re-
assessment of all Ebola patients
2. Fluid resuscitation
3. Electrolyte monitoring and correction
4. Glucose monitoring and management
5. Treatment of potential co-infections
6. Nutrition
7. Symptomatic care and prevention of
complications
8. Management of complications
The main priority is
to transfer patients
to a location where
they can receive
supportive care.
31. 30
Systematic assessment and
Re-assessment of all EVD Patients
• Staffing ratio of 1 or more
clinicians for 4 patients
• Assessments (evaluation of each
patient) performed at least 3 times
per 24 hours
• Close monitoring of patients to
allow recognition of and reaction
to acute changes in condition
32. 31
Systematic Assessment and
Re-assessment of all EVD Patients
§ Low systolic blood pressure (SBP) in either adults or children or delayed capillary refill and cold
extremities in a child
§ Altered mentation, delirium or seizure
§ Tachypnea (fast respiratory rate)
§ Weak or rapid pulse
§ Oliguria (urine output < 0.5 ml/kg/hour in adults; < 1.0 ml/kg/hour in children) or
§ Anuria
§ Haemorrhagic manifestations
§ Severe hypoglycaemia (glucose < 54 mg/dl or < 3 mmol/l)
§ SpO2 < 92%
§ Severe electrolyte, metabolic, acid-base abnormalities
§ Severe vomiting and/or diarrhoea
§ Severe weakness with inability to ambulate or eat/drink.
• Identification of patients at high risk for complications, including:
• Resuscitation should be initiated
• Patients should be placed in the area of the treatment unit designated
for the care of the critically ill
34. 33
Fluid Resuscitation
• Patients with Ebola often present with or
develop one or more of the following:
– Volume depletion (dehydration), sepsis,
haemorrhage and/or shock
• Management:
– Oral rehydration in patients who can
drink
– Intravenous administration in those who
are unable to drink or who have severe
dehydration or shock
35. 34
Electrolyte Monitoring and Correction
• Complete daily labs during acute
phase of illness and haematology on
admission and as needed
• Ensure appropriate and timely
correction of electrolyte
abnormalities, including:
– Hypokalaemia, hyperkalaemia,
hypomagnesemia, hypocalcaemia,
hyponatraemia, hypernatraemia
Detailed guidance on electrolyte management
can be found in WHO Optimized Supportive
Care for Ebola Virus Disease found here.
36. 35
Glucose Monitoring and Management
• Hypoglycaemia is frequently seen in
patients with Ebola (especially infants and
children) and should be managed to avoid
complications
• Recommendations:
– Serum glucose checked at least 3 times a
day with vital signs
– Intravenous (IV) glucose management
as needed
37. 36
Treatment of Potential Co-infections
• Bacterial co-infection
–Empiric treatment with antibiotics is
recommended for patients with Ebola
• Co-infection with malaria
– Empiric antimalarial therapy should
be administered to all febrile patients
with suspect and confirmed Ebola
– Stop treatment once malaria testing is
negative or the treatment course is
finished.
38. 37
Nutrition
• On admission, assess the nutritional status
of all patients with Ebola, including:
–Body weight, height, and in children, mid-
upper arm circumference
–Signs of malnutrition
–Current appetite status
• Enteral nutrition should be provided and
advanced as tolerated
• IV dextrose provided for patients that cannot
take oral food and with evidence of
hypoglycaemia
39. 38
Prevention of Complications
• Feeding
–Encourage early enteral
nutrition
• Stress ulcer prophylaxis
–Use of a proton pump inhibitor
or H2 receptor blocker in
critically ill patients at high risk of
bleeding
40. 39
Prevention of Complications
• Early Mobility
–Assess patient daily for early mobility
– Once patient is improving, then encourage
early mobility and ambulation to prevent
pressure ulcers and thrombotic events
–Provide assistance for patient to sit up,
dangle on side of bed, then to stand and
walk
–If unable to mobilize, turn patient in bed
every 2–4 hours to prevent pressure ulcers
41. 40
Management of complications
• The complications of Ebola include:
Seizure Bleeding at the site of IV
Altered mental state and encephalopathy Intracerebral haemorrhage
Haemorrhage Acute renal failure/kidney injury
Haematemesis Metabolic acidosis
Haematochezia Hypoxic respiratory failure
Vaginal bleeding Sepsis and septic shock
Gingival bleeding
42. 41
UN, WHO and CDC’s EVD Resources
DHMOSH Ebola Resource Page https://hr.un.org/page/ebola
UNMD Ebola Risk Mitigation Plan (July 2019)
https://hr.un.org/sites/hr.un.org/files/Ebola%20Checklist_DHMOS
HPH_2019-05_FINAL_Eng_2.pdf
Ebola Preparedness And Response: A Checklist for UN
Health Facilities (May 2019)
https://hr.un.org/sites/hr.un.org/files/Ebola%20Checklist_DHMOS
HPH_2019-05_FINAL_Eng_2.pdf
PPE Calculator https://www.cdc.gov/vhf/ebola/healthcare-us/ppe/calculator.html
Ebola Virus Disease: Standard Precautions and How to Use
EVD PPE Calculator [Video]
https://www.youtube.com/watch?v=EyJqhhLwgX4
Personal protective equipment for use in a filovirus disease
outbreak (November 2016)
https://www.who.int/publications/i/item/9789241549721
Optimized supportive care for Ebola virus disease: clinical
management standard operating procedures (2019)
https://apps.who.int/iris/handle/10665/325000
Implementation and management of contact tracing for
Ebola virus disease (July 2015)
https://www.who.int/publications/i/item/WHO-EVD-Guidance-
Contact-15.1
Manual for the care and management of patients in Ebola
Care Units/Community Care Centres (Jan 2015)
https://apps.who.int/iris/bitstream/handle/10665/149781/WHO_E
VD_Manual_ECU_15.1_eng.pdf